{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:46:56Z","timestamp":1793652416813,"version":"4.5.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["EudraCT 2010\u2013020808\u201329"],"award-info":[{"award-number":["EudraCT 2010\u2013020808\u201329"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["FP7\u2013242209-BIOSTAT-CHF"],"award-info":[{"award-number":["FP7\u2013242209-BIOSTAT-CHF"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ijcard.2023.131664","type":"journal-article","created":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T12:38:58Z","timestamp":1703162338000},"page":"131664","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Differential biomarker expression in heart failure patients with and without mitral regurgitation: Insights from BIOSTAT-CHF"],"prefix":"10.1016","volume":"399","author":[{"given":"Marianna","family":"Adamo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Pagnesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Di Pasquale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Ravera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Dickstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leong L.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan D.","family":"Anker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"Cleland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerasimos S.","family":"Filippatos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chim C.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Ponikowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilesh J.","family":"Samani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiez","family":"Zannad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk J.","family":"van Veldhuisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Lipsic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriaan","family":"Voors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Metra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ijcard.2023.131664_bb0005","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jacbts.2017.07.010","article-title":"Molecular epidemiology of heart failure: translational challenges and opportunities","volume":"2","author":"Smith","year":"2017","journal-title":"JACC Basic Transl. Sci."},{"issue":"5","key":"10.1016\/j.ijcard.2023.131664_bb0010","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/ejhf.1811","article-title":"A network analysis to identify pathophysiological pathways distinguishing ischaemic from non-ischaemic heart failure","volume":"22","author":"Sama","year":"2020","journal-title":"Eur. J. Heart Fail."},{"issue":"10","key":"10.1016\/j.ijcard.2023.131664_bb0015","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1093\/cvr\/cvaa279","article-title":"Differences in biomarkers and molecular pathways according to age for patients with HFrEF","volume":"117","author":"Ferreira","year":"2021","journal-title":"Cardiovasc. Res."},{"issue":"10","key":"10.1016\/j.ijcard.2023.131664_bb0020","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1002\/ejhf.2276","article-title":"Impact of mitral regurgitation in patients with worsening heart failure: insights from BIOSTAT-CHF","volume":"23","author":"Pagnesi","year":"2021","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2023.131664_bb0025","doi-asserted-by":"crossref","DOI":"10.1007\/s00392-022-01991-7","article-title":"Clinical impact of changes in mitral regurgitation severity after medical therapy optimization in heart failure","author":"Pagnesi","year":"2022","journal-title":"Clin. Res. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcard.2023.131664_bb0030","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ejhf.2333","volume":"24","author":"McDonagh","year":"2022","journal-title":"Eur. J. Heart Fail."},{"issue":"6","key":"10.1016\/j.ijcard.2023.131664_bb0035","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/ehf2.12339","article-title":"A meta-analysis of MitraClip combined with medical therapy vs. medical therapy alone for treatment of mitral regurgitation in heart failure patients","volume":"5","author":"Giannini","year":"2018","journal-title":"ESC Heart Fail."},{"issue":"1","key":"10.1016\/j.ijcard.2023.131664_bb0040","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jcin.2020.09.050","article-title":"COAPT-like profile predicts long-term outcomes in patients with secondary mitral regurgitation undergoing MitraClip implantation","volume":"14","author":"Adamo","year":"2021","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2023.131664_bb0045","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jprot.2013.10.009","article-title":"Proteomics discovery of biomarkers for mitral regurgitation caused by mitral valve prolapse","volume":"94","author":"Tan","year":"2013","journal-title":"J. Proteome"},{"issue":"1","key":"10.1016\/j.ijcard.2023.131664_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12014-015-9097-2","article-title":"New biomarkers for primary mitral regurgitation","volume":"12","author":"Deroyer","year":"2015","journal-title":"Clin. Proteomics"},{"issue":"6","key":"10.1016\/j.ijcard.2023.131664_bb0055","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/ejhf.531","article-title":"A systems BIOlogy study to TAilored treatment in chronic heart failure: rationale, design, and baseline characteristics of BIOSTAT-CHF","volume":"18","author":"Voors","year":"2016","journal-title":"Eur. J. Heart Fail."},{"issue":"4","key":"10.1016\/j.ijcard.2023.131664_bb0060","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jjcc.2015.02.015","article-title":"B-type natriuretic peptide response and reverse left ventricular remodeling after surgical correction of functional mitral regurgitation in patients with advanced cardiomyopathy","volume":"66","author":"Kainuma","year":"2015","journal-title":"J. Cardiol."},{"key":"10.1016\/j.ijcard.2023.131664_bb0065","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ijcard.2018.06.041","article-title":"Two-year cardiac mortality after MitraClip treatment of functional mitral regurgitation in ischemic and non-ischemic dilated cardiomyopathy","volume":"269","author":"Godino","year":"2018","journal-title":"Int. J. Cardiol."},{"issue":"9","key":"10.1016\/j.ijcard.2023.131664_bb0070","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/ejhf.2295","article-title":"Antigen carbohydrate 125 as a biomarker in heart failure: a narrative review","volume":"23","author":"N\u00fa\u00f1ez","year":"2021","journal-title":"Eur. J. Heart Fail."},{"issue":"2","key":"10.1016\/j.ijcard.2023.131664_bb0075","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/joim.13053","article-title":"Tumour biomarkers: association with heart failure outcomes","volume":"288","author":"Shi","year":"2020","journal-title":"J. Intern. Med."},{"issue":"3","key":"10.1016\/j.ijcard.2023.131664_bb0080","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1751-7133.2011.00260.x","article-title":"Serum carbohydrate antigen 125 levels in nonischemic dilated cardiomyopathy: a useful biomarker for prognosis and functional mitral regurgitation","volume":"18","author":"Karaca","year":"2012","journal-title":"Congest Hear Fail."},{"issue":"23","key":"10.1016\/j.ijcard.2023.131664_bb0085","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA."},{"issue":"6","key":"10.1016\/j.ijcard.2023.131664_bb0090","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Guti\u00e9rrez","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.ijcard.2023.131664_bb0095","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1161\/CIRCHEARTFAILURE.113.000952","article-title":"Fibroblast growth factor-23 and cardiovascular disease in the general population: the multi-ethnic study of atherosclerosis","volume":"7","author":"Kestenbaum","year":"2014","journal-title":"Circ. Heart Fail."},{"issue":"21","key":"10.1016\/j.ijcard.2023.131664_bb0100","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1093\/eurheartj\/ehr215","article-title":"The phosphatonin fibroblast growth factor 23 links calcium-phosphate metabolism with left-ventricular dysfunction and atrial fibrillation","volume":"32","author":"Seiler","year":"2011","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2023.131664_bb0105","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijcard.2017.10.010","article-title":"Fibroblast growth factor 23 is related to profiles indicating volume overload, poor therapy optimization and prognosis in patients with new-onset and worsening heart failure","volume":"253","author":"ter Maaten","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2023.131664_bb0110","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/308190","article-title":"Low magnesium levels and FGF-23 dysregulation predict mitral valve calcification as well as intima media thickness in predialysis diabetic patients","volume":"2015","author":"Silva","year":"2015","journal-title":"Int. J. Endocrinol."},{"issue":"22","key":"10.1016\/j.ijcard.2023.131664_bb0115","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1136\/heartjnl-2016-309404","article-title":"Association of inflammatory, lipid and mineral markers with cardiac calcification in older adults","volume":"102","author":"Bortnick","year":"2016","journal-title":"Heart."},{"key":"10.1016\/j.ijcard.2023.131664_bb0120","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.atherosclerosis.2019.04.215","article-title":"Biomarkers of mineral metabolism and progression of aortic valve and mitral annular calcification: the multi-ethnic study of atherosclerosis","volume":"285","author":"Bortnick","year":"2019","journal-title":"Atherosclerosis."},{"issue":"45","key":"10.1016\/j.ijcard.2023.131664_bb0125","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1093\/eurheartj\/ehaa819","article-title":"Prognostic importance of the transmitral pressure gradient in mitral annular calcification with associated mitral valve dysfunction","volume":"41","author":"Bertrand","year":"2020","journal-title":"Eur. Heart J."},{"issue":"17","key":"10.1016\/j.ijcard.2023.131664_bb0130","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1016\/j.jacc.2015.08.872","article-title":"Mitral annulus calcification","volume":"66","author":"Abramowitz","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcard.2023.131664_bb0135","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.hfc.2017.08.008","article-title":"Growth hormone as biomarker in heart failure","volume":"14","author":"Marra","year":"2018","journal-title":"Heart Fail. Clin."},{"issue":"2","key":"10.1016\/j.ijcard.2023.131664_bb0140","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0735-1097(01)01385-7","article-title":"Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone","volume":"38","author":"Anker","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"issue":"15","key":"10.1016\/j.ijcard.2023.131664_bb0145","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1161\/CIRCULATIONAHA.117.032474","article-title":"Leptin-aldosterone-neprilysin axis: identification of its distinctive role in the pathogenesis of the three phenotypes of heart failure in people with obesity","volume":"137","author":"Packer","year":"2018","journal-title":"Circulation."},{"issue":"11","key":"10.1016\/j.ijcard.2023.131664_bb0150","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1093\/eurjhf\/hfs111","article-title":"High leptin and resistin expression in chronic heart failure: adverse outcome in patients with dilated and inflammatory cardiomyopathy","volume":"14","author":"Bobbert","year":"2012","journal-title":"Eur. J. Heart Fail."},{"issue":"3","key":"10.1016\/j.ijcard.2023.131664_bb0155","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1136\/hrt.82.3.352","article-title":"Inappropriately low plasma leptin concentration in the cachexia associated with chronic heart failure","volume":"82","author":"Murdoch","year":"1999","journal-title":"Heart."},{"issue":"2\u20133","key":"10.1016\/j.ijcard.2023.131664_bb0160","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0167-5273(00)00397-1","article-title":"Leptin serum levels in cachectic heart failure patient. Relationship with tumor necrosis factor-\u03b1 system","volume":"76","author":"Filippatos","year":"2000","journal-title":"Int. J. Cardiol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527323017990?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527323017990?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T21:06:10Z","timestamp":1759093570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527323017990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":32,"alternative-id":["S0167527323017990"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2023.131664","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential biomarker expression in heart failure patients with and without mitral regurgitation: Insights from BIOSTAT-CHF","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2023.131664","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"131664"}}